As biomanufacturing capacity becomes strained, several new methods for producing biologics are being investigated by biotechnology companies.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Dove, A. Uncorking the biomanufacturing bottleneck. Nat Biotechnol 20, 777–779 (2002). https://doi.org/10.1038/nbt0802-777
Issue Date:
DOI: https://doi.org/10.1038/nbt0802-777
- Springer Nature America, Inc.
This article is cited by
-
Versatile biomanufacturing through stimulus-responsive cell–material feedback
Nature Chemical Biology (2019)
-
Versatile and on-demand biologics co-production in yeast
Nature Communications (2018)
-
Expression of Histophilus somni IbpA DR2 protective antigen in the diatom Thalassiosira pseudonana
Applied Microbiology and Biotechnology (2017)
-
Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care
Nature Communications (2016)
-
The transgenic animal platform for biopharmaceutical production
Transgenic Research (2016)